Prostate cancer outcome: Epidemiology and biostatistics

Analytical and Quantitative Cytology and Histology

Volumn 27, Issue 4, 2005, Pages 211-217

  Burke, Harry B ^a,b   Bostwick, David G ^a   Meiers, Isabelle ^a   Montironi, Rodolfo ^c  

^a BOSTWICK LABORATORIES   (United States)

^b GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

^c UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

Author keywords

Biostatistics; Computer assisted diagnosis; Patient outcome assessment; Prognosis; Prostate cancer; TNM staging system

Indexed keywords

ANDROGEN RECEPTOR; BIOLOGICAL MARKER; CELL ADHESION MOLECULE; CYTOSKELETON PROTEIN; DNA; GROWTH FACTOR; PROSTATE SPECIFIC ANTIGEN; TUMOR SUPPRESSOR PROTEIN;

ACCURACY; CANCER EPIDEMIOLOGY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER STATISTICS; COMPUTER ASSISTED DIAGNOSIS; GLEASON SCORE; HUMAN; OUTCOMES RESEARCH; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PROSTATE CANCER; PROSTATECTOMY; REGRESSION ANALYSIS; REVIEW;

BIOMETRY; HUMANS; MALE; MODELS, STATISTICAL; NEOPLASM STAGING; PROGNOSIS; PROSTATIC NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 24144498392     PISSN: 08846812     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (25)

1. Jemal A, Tiwari RC, Murray T, Ghafoor A, Samuels A, Ward E, Feuer EJ, Thun MJ: Cancer statistics, 2004. CA Cancer J Clin 2004;54:8-29
2. Sakr WA, Haas GP, Cassin BF, Pontes JE, Crissman JD: The frequency of carcinoma and intraepithelial neoplasia of the prostate in young male patients. J Urol 1993;150:379-385
3. Burke HB: Artificial neural networks for cancer research: Outcome prediction. Semin Surg Oncol 1994;10:73-79
4. Burke HB: Statistical Analysis of Complex Systems in Biomedicine. New York, Springer-Verlag, 1996, pp 251-258
5. Burke HB: Prognosis. Atlanta, American Cancer Society, 2004
6. Burke HB, Henson DE: Criteria for prognostic factors and for an enhanced prognostic system. Cancer 1993;72:3131-3135
7. Burke HB, Hutter RVP, Henson DE: Breast carcinoma. In UICC Prognostic Factors in Cancer. Edited by P Hermanek, MK Gospadoriwicz, DE Henson, RVP Hutter, LH Sobin. Berlin, Springer-Verlag, 1995, pp 165-176
8. Carter BS, Carter HB, Isaacs JT: Epidemiologic evidence regarding predisposing factors to prostate cancer. Prostate 1990;16:187-197
9. Oishi K, Yoshida O, Schroeder FH: The geography of prostate cancer and its treatment in Japan. Cancer Surv 1995;23:267-280
10. Camp NJ, Tavtigian SV: Meta-analysis of associations of the Ser217Leu and Ala541Thr variants in ELAC2 (HPC2) and prostate cancer. Am J Hum Genet 2002;71:1475-1478
11. Breslow N, Chan CW, Dhom G, Drury RA, Franks LM, Gellei B, Lee YS, Lundberg S, Sparke B, Sternby NH, Tulinius H: Latent carcinoma of prostate at autopsy in seven areas: The International Agency for Research on Cancer, Lyons, France. Int J Cancer 1977;20:680-688
12. Bostwick DG, Burke HB, Djakiew D, Euling S, Ho SM, Landolph J, Morrison H, Sonawane B, Shifflett T, Waters DJ, Timms B: Human prostate cancer risk factors: Review commissioned by the U.S. Environmental Protection Agency, 2003. Cancer 2004;101:2371-2490
13. Bostwick DG: Practical clinical application of predictive factors in prostate cancer: A review with an emphasis on quantitative methods in tissue specimens. Anal Quant Cytol Histol 1998;20:323-342
14. Tricoli JV, Schoenfeldt M, Conley BA: Detection of prostate cancer and predicting progression: Current and future diagnostic markers. Clin Cancer Res 2004;10:3943-3953
15. Bostwick DG, Burke HB: Prediction of individual patient outcome in cancer: Comparison of artificial neural networks and Kaplan-Meier methods. Cancer 2001;91:1643-1646
16. Gospodarowiez M, Benedet L, Hutter RV, Fleming I, Henson DE, Sobin LH: History and international developments in cancer staging. Cancer Prevent Control 1998;2:262-268
17. Greene FL, Page DL, Fleming ID, Fritz AG, Balch CM, Haller DG, Morrow M (editors): AJCC Cancer Staging Manual. Sixth edition. New York, Springer, 2002
18. Fisher B, Gebhardt MC: The evolution of breast cancer surgery: Past, present, and future. Semin Surg Oncol 1978;5: 385-394
19. Burke HB, Hoang A, Iglehart JD, Marks JR: Predicting response to adjuvant and radiation therapy in early stage breast cancer. Cancer 1998;82:874-877
20. Burke HB, Goodman PH, Rosen DB, Henson DE, Weinstein JN, Harrell FE Jr, Marks JR, Winchester DP, Bostwick DG: Artificial neural networks improve the accuracy of cancer survival prediction. Cancer 1997;79:857-862
21. Edge SB, Sobin LH, Page DL, Gospodarowicz, Greene FL, Winchester DP: Re: Colon cancer survival rates with the new American Joint Committee on Cancer, sixth edition, staging. J Natl Cancer Inst 2005;97:463-464
22. Burke HB: Outcome prediction and the future of the TNM staging system. J Natl Cancer Inst 2004;96:1408-1409
23. Burke HB: Re: Colon cancer survival rates with the new American Joint Committee on Cancer, sixth edition, staging. J Natl Cancer Inst 2005;97:464-465
24. Bostwick DG, Adolfsson J, Burke HBB, Damber J-E, Huland H, Pavone-Maculoso M, Water DJ: Epidemiology and statistical methods in prediction of patient outcome. Scand J Urol Nephrol 2005;216:94-110
25. Burke HB, Hoang A, Iglehart JD, Marks JR: Predicting response to adjuvant and radiation therapy in patients with early stage breast carcinoma. Cancer 1998;82:874-877